ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

Clinical Manifestations Of Ovarian Hormonal Disorders: Polycystic Ovary Syndrome And Medical Problem Of Menopause

Updated on February 17, 2014

Polycystic Ovary Syndrome

This is a heterogenous disorder clinically characterized by ovulatory failure, hirsuitism, obesity and infertility. The ovaries are enlarged, multicystic and they show hyperplastic theca cells around the cysts.
This is a heterogenous disorder clinically characterized by ovulatory failure, hirsuitism, obesity and infertility. The ovaries are enlarged, multicystic and they show hyperplastic theca cells around the cysts. | Source

Polycyctic Ovary Syndrome

The incidence of Polycystic Ovary syndrome globally which is in an increase is of huge significance to global health. Also understanding the period of menopause helps women prepare and adapt well to it.

Polycyctic Ovary Syndrome

This is a heterogenous disorder clinically characterized by ovulatory failure, hirsuitism, obesity and infertility. The ovaries are enlarged, multicystic and they show hyperplastic theca cells around the cysts. Only very small amounts of estradiol are produced by the immature follicles. Excessive amounts of androgens are produced by the hyperplastic theca cells and stromal cells. The enlarged cystic ovaries on both sides can be made out by bimanual examination of diagnostic laparoscopy. Therapeutic measures are designed to restore fertility, normalize menstruation and reverse hirsuitism.

Dysfunctional uterine bleeding: Excessive or more frequent menstrual bleeding resulting from functional disturbances, but without obvious pathological causes is called dysfunctional uterine bleeding. Hormonal imbalance and nutritional, psychologic and hematologic factors play contributory roles. This is a common gynecological problem in women in the fourth and fifth decades of life.

Medical Problem Of Menopause

Women attain menopause usually between 40 and 47 years. Menopause is taken to be complete when a women has not had periods for one year in the absence of any pathological condition or obvious features of ovarian deficiency.

Physiological changes: Menopause represents a form of primary ovarian failure. The number of ovarian follicles steadily decline with age and these follicles become less and less sensitive to the action of FSH as age advances, as women reach menopause, the FSH/LH reach high levels and the estrogen levels fall and because of diminishing number of follicles in the ovary production of estrogen is reduced. In many subjects, the development of menopause may be quite uneventful and asymptomatic. The following four groups of symptoms may develop in those who become symptomatic.

General symptoms: These include insomnia, nervousness, anxiety, depression, irritability, headache, dizziness and joint pains.

Vasomotor symptoms: These consist of hot flushes, inappropriate perspiration and palpitation. These occur frequently as sudden burning feeling all over the body followed by sweating, faintness and palpitation. Sometimes, these symptoms are very frequent and disabling.

Atrophic Changes in the genitalia: The main symptoms are urinary stress incontinence, vaginal atrophy, irritant vaginal discharge, dryness, dyspareunia, vulvar pruritus, and/or burning.

Cosmetic effects: Certain characteristic changes include the development of fine folds and marks radiating from the mouth, sagging of the infra-orbital fold of skin on the face, sagging and atrophy of the breasts and generalized wasting of adipose tissue. Osteoporosis is common and this may lead to fractures of the vertebrae and limbs.


menstrual-cycle-menopause | Source


In troublesome cases, estrogen supplementation is instituted. Definite indications for estrogen therapy are: hot flushes, dyspareunia, cosmetic disability and osteoporosis.

Several Preparations Of Estrogens Are Used In The Therapy Of Various Disorders

Routine Of Administration
Parenteral (s/c)
0.4 mg
Estrone sulphate
0.4 mg
Semi synthetic
Ethinyl estradiol
0.01 to 0.05 mg
0.01 to 1 mg
4 mg
12 to 24 mg
12 to 24 mg
Oral contraceptive
Fosfestrol (Honvan)
Oral and parenteral
100 to 250 mg used to treat prostatic carcinoma

Estrogens are given orally in cycles of three weeks followed by a free interval for one week. In those cases with intact uterus, progestogens are employed in the third week. Estrogen therapy is absolutely contraindicated in those with cerebrovascular accidents, recent myocardial infarction, carcinoma of breast, pancreatitis, cholecystitis, endometrial carcinoma and recurrent venous thromboembolism. Relative contraindications include cystic disease of the breasts, heavy smoking, hypertension, family history of carcinoma of the breast, liver diseases, cholelithiasis, diabetes mellitus, endometrial hyperplasia, gross obesity and a single episode of thrombophlebitis.

© 2014 Funom Theophilus Makama


    0 of 8192 characters used
    Post Comment

    No comments yet.


    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at:

    Show Details
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the or domains, for performance and efficiency reasons. (Privacy Policy)
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)